Evaluation of uterine receptivity after gonadotropin releasing hormone agonist administration as an oocyte maturation trigger: a rodent model
@article{Ezoe2019EvaluationOU, title={Evaluation of uterine receptivity after gonadotropin releasing hormone agonist administration as an oocyte maturation trigger: a rodent model}, author={Kenji Ezoe and Nana Murata and Akiko Yabuuchi and Tamotsu Kobayashi and Keiichi Kato}, journal={Scientific Reports}, year={2019}, volume={9} }
In natural cycle or minimal stimulation cycle IVF, buserelin acetate (buserelin), a gonadotropin-releasing hormone agonist, is often used as a maturation trigger; however, its effect on pregnancy outcomes remains unclear. Therefore, in the present study, we compared uterine receptivity in buserelin-administered mice with that in human chorionic gonadotropin (hCG)-administered mice during the peri-implantation period. Implantation, decidualisation, and term-pregnancy were impaired following hCG…
5 Citations
Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I-II endometriosis.
- MedicineF&S science
- 2020
Prolactin receptor expression and its role in trophoblast outgrowth in human embryos.
- Biology, MedicineReproductive biomedicine online
- 2021
Effects of fatty acid supplementation during vitrification and warming on the developmental competence of mouse, bovine and human oocytes and embryos.
- Chemistry, MedicineReproductive biomedicine online
- 2021
Time from trophectoderm biopsy to vitrification affects the developmental competence of biopsied blastocysts
- MedicineReproductive medicine and biology
- 2022
The vitrification of biopsied blastocysts in the process of re‐expansion impairs outgrowth competence; therefore, blastocyst vitrification should be performed immediately after TE biopsy and before initiation of re-expansion.
Potential implications of gonadotropin-releasing hormone analogues in assisted reproductive technology
- BiologyEmerging Issues in Climate Smart Livestock Production
- 2022
References
SHOWING 1-10 OF 86 REFERENCES
Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
- Medicine, BiologyHuman reproduction
- 1996
The use of GnRHa to induce ovulation in IVF patients, who are at high risk for developing OHSS, effectively eliminates this risk without affecting other parameters of the stimulation cycle.
Endocrinology: Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study
- Medicine, Biology
- 1996
The use of GnRHa to induce ovulation in IVF patients, who are at high risk for developing OHSS, effectively eliminates this risk without affecting other parameters of the stimulation cycle.
Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.
- Medicine, BiologyFertility and sterility
- 1991
Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
- Medicine, BiologyThe Journal of clinical endocrinology and metabolism
- 1990
Gnosis agonist is able to simulate a midcycle surge of gonadotropins, leading to follicular maturation and pregnancy, and further work is needed to determine whether there is any clinical advantage of GnRH agonist over hCG administration with regard to pregnancy rates.
Ovarian stimulation using human chorionic gonadotrophin impairs blastocyst implantation and decidualization by altering ovarian hormone levels and downstream signaling in mice.
- BiologyMolecular human reproduction
- 2014
It is demonstrated that ovarian stimulation using hCG alone impairs implantation, decidualization and fetal development of mice by generating abnormal ovarian hormone levels and anomalous ovarian hormone secretion induced by ovarian stimulation alters the spatiotemporal expression of progesterone receptors and their downstream genes, especially in the uterine epithelium.
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
- Medicine, BiologyFertility and sterility
- 1992
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
- Biology, MedicineReproductive biomedicine online
- 2012
Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
- Biology, MedicineJBRA assisted reproduction
- 2016
It has been found that Dual Triggering for poor responder patients had a statistically significant increase in the number of retrieved oocytes, mature oocyte, and fertilized embryos in the positive beta hCG rate, implantation rate, and newborn/transferred embryo (TE) rate.
Ovarian hyperstimulation inhibits embryo implantation in the mouse
- Biology, MedicineJournal of in Vitro Fertilization and Embryo Transfer
- 2005
The data suggest that, in the mouse, ovarian hyperstimulation impedes implantation by causing adverse changes in uterine receptivity.
Ovarian stimulation modulates steroid receptor expression and spheroid attachment in peri-implantation endometria: studies on natural and stimulated cycles.
- Medicine, BiologyFertility and sterility
- 2011